[{"Assets_0_Q3_USD":367022000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":87663000.0,"NetIncomeLoss_1_Q3_USD":26340000.0,"NetIncomeLoss_3_Q3_USD":64800000.0,"StockholdersEquity_0_Q3_USD":334376000.0,"EarningsPerShareBasic_1_Q3_USD":0.23,"EarningsPerShareBasic_3_Q3_USD":0.57,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":113875000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":114349000.0,"Ticker":"CORT","CIK":"1088856","name":"CORCEPT THERAPEUTICS INC","OfficialName":"Corcept Therapeutics Incorporated Common Stock","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2458327425.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20191107"}]